Condition

Cognitively Normal

ClinicalTrials.gov condition label

Clinical trials2

Recruiting1

Common interventions2

Lead sponsors shown2

Clinical trials

2 shown

PET Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Using [18F]-PI-2620NCT05456503 · 2022-09-19

RECRUITING

Longitudinal Changes of [18F]PI-2620 Positron Emission Tomography in Subjects With Cognitively Normal, Mild Cognitive Impairment and Alzheimer's DiseaseNCT03903211 · 2019-04-09

COMPLETED

Common interventions

[18F]-PI-2620DRUG1[18F]PI-2620DRUG1

Leading sponsors

Jae Seung Kim1University of Pennsylvania1

Trial status mix

COMPLETED1

RECRUITING1

Phase mix

PHASE21

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.